DrugJul 3, 2024
Zilretta recall — FDA D-0567-2024
Failed Dissolution Specifications - did not meet the acceptance criteria for IVR Level 3 testing at 9 months 2-8¿C followed by 6 weeks at 25¿C
Class IIFDA: OngoingPACIRA PHARMACEUTICALS Inc.
Recall history in this database
Classification mix: Class II: 3.
DrugJun 19, 2024
ZILRETTA Drug Vial Label: Zilretta recall — FDA D-0546-2024
Failed Stability Specifications - at 12 months 2-8 degrees C followed by 6 weeks at 25 degrees C.
Class IIFDA: OngoingPACIRA PHARMACEUTICALS Inc.
DrugMar 6, 2013
Pacira Pharmaceuticals EXPAREL recall — FDA D-168-2013
Subpotent; bupivacaine
Class IIFDA: TerminatedPacira Pharmaceuticals, Inc.
Understanding this recall history
This page summarizes recall records in which the official source identifies Pacira Pharmaceuticals, Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.